These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2813333)

  • 1. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
    Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
    Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1994 Mar; 9(2):225-9. PubMed ID: 8190724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
    Moriyoshi Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
    Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats.
    Taguchi S; Green GM; Nakano I; Hatta Y
    Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous insulin in pancreatic secretion in rats.
    Iwabe C; Shiratori K; Shimizu K; Hayashi N
    Pancreatology; 2001; 1(4):300-5. PubMed ID: 12120208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S; Li P; Chang TM; Chey WY
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
    Miyasaka K; Nakamura R; Funakoshi A; Kitani K
    Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
    Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y
    Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of intraduodenal administration of somatostatin analogue SDZ CO 611 on rat pancreatic exocrine secretion.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1993 Jul; 8(4):471-5. PubMed ID: 8361968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous CCK in regulation of interdigestive pancreatic exocrine secretion in sheep (Ovis aries).
    Tachibana S; Onaga T; Mineo H; Kato S
    Comp Biochem Physiol A Physiol; 1995 Sep; 112(1):103-9. PubMed ID: 7553326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.